The Barbershop Trial: Key Takeaways
April 1st 2018On March 12, 2018, the New England Journal of Medicine published a cluster-randomized trial of an intervention by pharmacists who were operating under collaborative practice agreements to initiate, titrate, monitor, and otherwise manage drug therapy for non-Latino African American men in barbershops.
Read More
A Trifecta of Threats (and Opportunities) Set to Become Mainstream in Pharmacy
January 16th 2017It was with great fanfare that Amazon announced early last month that it had made its first drone delivery from its Cambridge, England, facility. I thought it interesting that the Wall Street Journal’s article about the launch of the service used medication delivery as an exemplar to highlight the advantages of drone delivery not once, but twice.
Read More
Opportunity Abounds, but Emerging Surplus of Pharmacists Means Differentiation is Key
October 31st 2016It’s an exciting time for the profession of pharmacy, with diversity of opportunity continuing to grow dramatically as our health care system redesigns itself, slowly but surely moving from a system engineered for “sick care” encounters and mechanical throughput to one oriented toward health improvement and outcomes-based value.
Read More
Expressing Value in an Era of Outlier Drug Pricing: Our Round Peg, Square Hole Problem
October 11th 2016It seems that just about every month now, there is another public outcry in response to a new innovator product that is priced well above convention or to a dramatic price hike for a product that has been in the marketplace for years.
Read More